Wei Haiming
Professor
Life Science
University of Science and Technology of China
China
Biography
Wei Haiming, professor and Ph.D. supervisor at School of Life Sciences, USTC. July 1996-October 2000, Assistant Researcher, Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences; November 2000-August 2001, Associate Researcher, Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences; September 2001-December 2005, Associate Professor, School of Life Science of University of Science and Technology of China (USTC); Since December 2005, Professor, School of Life Science of USTC. August 1993-July 1997, Master Degree Candidate, Shandong Academy of Medical Sciences; August 2000-July 2003, Doctoral Candidate, Shandong University
Research Interest
The research in our laboratory focuses on three main topics. 1) The development and transcription regulation of human NK cells. 2) The relationship between human NK subsets and major diseases. We are interested in understanding the mechanisms of hepatitis, Immune escape by Hepatitis B Viruses and the development of auto-immune diseases. 3) Biological Treatment Technology of tumors based on innate immunity. We are currently evaluating the anti-tumor immunochemotherapy of IL-12 based on “pre-existing immunity”. We are also focusing to research and produce the anti-tumor medicine of IL-12.
Publications
-
Lv S, Wang J, Dou S, Yang X, Ni X, Sun R, Tian Z, Wei H. Nanoparticles encapsulating HBV-CpG induce therapeutic immunity against hepatitis B virus infection. Hepatology. 2014Feb 59(2):385-94
-
Zheng X, Cheng M, Fu B, Fan X, Wang Q, Yu X, Sun R, Tian Z, Wei H. Targeting LUNX inhibits non-small cell lung cancer growth and metastasis. Cancer Res. 2015 Mar 15;75(6):1080-90
-
Zheng X, Fan X, Fu B, Zheng M, Zhang A, Zhong K, Yan J, Sun R, Tian Z, Wei H. EpCAM inhibition sensitizes chemoresistant leukemia to immune surveillance.Cancer Res. 2016 Oct 3. pii: canres.0842
